首页> 美国卫生研究院文献>Frontiers in Neurology >Monitoring in Neurointensive Care – The Challenge to Detect Delayed Cerebral Ischemia in High-Grade Aneurysmal SAH
【2h】

Monitoring in Neurointensive Care – The Challenge to Detect Delayed Cerebral Ischemia in High-Grade Aneurysmal SAH

机译:神经重症监护中的监测–在高级动脉瘤SAH中发现延迟性脑缺血的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Delayed cerebral ischemia (DCI) is a feared and significant medical complication following aneurysmal subarachnoid hemorrhage (aSAH). It occurs in about 30% of patients surviving the initial hemorrhage, mostly between days 4 and 10 after aSAH. Clinical deterioration attributable to DCI is a diagnosis of exclusion and especially difficult to diagnose in patients who are comatose or sedated. The latter are typically patients with a high grade on the World Federation of Neurosurgical Societies scale (WFNS grade 4–5), who represent approximately 40–70% of the patient population with ruptured aneurysms. In this group of patients, the incidence of DCI is often underestimated and higher when compared to low WFNS grade patients. To overcome difficulties in diagnosing DCI, which is especially relevant in sedated and comatose patients, the article reports the most recent recommendation for definition of DCI and discusses their advantages and problematic issues in neurocritical care practice. Finally, appropriate neuromonitoring techniques and their clinical impact in high-grade SAH patients are summarized.
机译:延迟性脑缺血(DCI)是动脉瘤性蛛网膜下腔出血(aSAH)后令人担忧的重大医学并发症。约有30%的患者在初次出血后幸存,多数在aSAH后4至10天之间发生。归因于DCI的临床恶化是诊断排除,尤其是在昏迷或镇静的患者中难以诊断。后者通常是世界神经外科协会联合会评分较高的患者(WFNS 4-5级),约占动脉瘤破裂患者总数的40-70%。在这组患者中,与低WFNS级患者相比,DCI的发生率经常被低估并且更高。为了克服诊断DCI的困难,这在镇静和昏迷患者中尤为重要,本文报道了有关DCI定义的最新建议,并讨论了其在神经重症监护实践中的优势和问题所在。最后,总结了适当的神经监测技术及其对高级别SAH患者的临床影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号